BiotechTube
Home/Elios Therapeutics/Dr. Thomas Wagner
DT

Dr. Thomas Wagner

Scientific Founder

Elios Therapeutics

Therapeutic Areas

Oncology

Elios Therapeutics Pipeline

DrugIndicationPhase
TLPO/TLPLDC VaccineHigh-risk, resected Stage III/IV Melanoma (adjuvant setting)Phase 2b

Leadership Team at Elios Therapeutics

PJ
Phillip Johnson
Chief Financial Officer
View full Elios Therapeutics profile